CTVA · NYSE · Agricultural Inputs

Corteva (CTVA)

Develops seed genetics and crop-protection products for farmers worldwide.

$81.33
vs last close+0.98 (+1.23%)

In millions of USD, except per-share figures

In millionsQ3 FY23Sep 2023Q4 FY23Dec 2023Q1 FY24Mar 2024Q2 FY24Jun 2024Q3 FY24Sep 2024Q4 FY24Dec 2024Q1 FY25Mar 2025Q2 FY25Jun 2025Q3 FY25Sep 2025Q4 FY25Dec 2025Q1 FY26Mar 2026Q2 FY26Jun 2026
Revenue2,5903,7074,4926,1122,3263,9784,4176,4562,6183,9104,9056,379
Cost of revenue1,6462,3662,5502,9181,5652,4962,3422,9321,6442,2542,3722,912
Gross profit9441,3411,9423,1947611,4822,0753,5249741,6562,5333,467
1,2091,1761,2451,5851,2261,1551,2481,6921,2441,4141,3781,552
Research & development335357332357348365335375351413341388
7006447361,0547086267511,1567318428771,164
General & administrative70007361,05470807511,15673108770
Other expenses1741751771741701641621611621591600
Operating income−2651656971,609−4653278271,832−2702421,1551,915
−179−488−215−271−168−239−43−28−100−772−297−290
Interest income5913035253339323129443427
Interest expense586241666660365246463647
Other non-operating income1214261742051021797−24547262610
Income before tax−444−3234821,338−633887841,804−370−5308581,625
Income tax expense−129−92106282−114138117422−627133408
Net income from continuing operations−315−2313761,056−519−506671,382−308−5377251,217
Discontinued operations−3−20470−211−11−66−10−12−2−52
Net income−321−2534191,053−524−416521,314−320−5527201,161
EPS, basic−$0.45−$0.36$0.60$1.51−$0.76−$0.06$0.95$1.93−$0.47−$0.82$1.07$1.73
EPS, diluted−$0.45−$0.36$0.60$1.51−$0.76−$0.06$0.95$1.92−$0.47−$0.82$1.07$1.73
Weighted average shares, basic708704700696691687685682679675673670
Weighted average shares, diluted708704703698691687687683679675674672
EBITDA−80518301,716−2614501,1162,157−24−1781,1912,254
Depreciation & amortization306312307312306302296301300306297339
EBIT−386−2615231,404−5671488201,856−324−4848941,915